Open Access

[Corrigendum] RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells

  • Authors:
    • Tao Liu
    • Yixiang Liao
    • Huangheng Tao
    • Jinmin Zeng
    • Gang Wang
    • Zhonghua Yang
    • Yongzhi Wang
    • Yu Xiao
    • Jiajie Zhou
    • Xinghuan Wang
  • View Affiliations

  • Published online on: March 12, 2025     https://doi.org/10.3892/ol.2025.14975
  • Article Number: 229
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Lett 15: [Related article:] 4129–4136, 2018; DOI: 10.3892/ol.2018.7847

Subsequently to the publication of this paper [and a corrigendum that was published to take account of errors that were made with the assembly of flow cytometric plots shown in Fig. 3A (see doi.org/10.3892/ol.2022.13211)], an interested reader drew to the attention of the Editor that the control β-actin RT-qPCR data in Fig. 1A and certain of the western blot data shown in Fig. 4C were strikingly similar to data that had already appeared in different form in articles that were published in the journals Oncology Letters and Oncotarget respectively, albeit these papers featured various of the abovementioned authors.

Upon examining their original raw data (which were also presented to the Editorial Office for our inspection), the authors realized how these errors occurred, and the revised versions of Figs. 1 and 4, containing the correct control β-actin RT-qPCR data in Fig. 1A and western blot data in Fig. 4C, are shown on the next page. The authors regret the errors that were made during the compilation of the original figures, and are grateful to the editor of Oncology Letters for allowing them the opportunity to publish a further Corrigendum. Furthermore, they apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

May-2025
Volume 29 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu T, Liao Y, Tao H, Zeng J, Wang G, Yang Z, Wang Y, Xiao Y, Zhou J, Wang X, Wang X, et al: [Corrigendum] RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells. Oncol Lett 29: 229, 2025.
APA
Liu, T., Liao, Y., Tao, H., Zeng, J., Wang, G., Yang, Z. ... Wang, X. (2025). [Corrigendum] RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells. Oncology Letters, 29, 229. https://doi.org/10.3892/ol.2025.14975
MLA
Liu, T., Liao, Y., Tao, H., Zeng, J., Wang, G., Yang, Z., Wang, Y., Xiao, Y., Zhou, J., Wang, X."[Corrigendum] RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells". Oncology Letters 29.5 (2025): 229.
Chicago
Liu, T., Liao, Y., Tao, H., Zeng, J., Wang, G., Yang, Z., Wang, Y., Xiao, Y., Zhou, J., Wang, X."[Corrigendum] RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells". Oncology Letters 29, no. 5 (2025): 229. https://doi.org/10.3892/ol.2025.14975